92 related articles for article (PubMed ID: 24913992)
1. Emergence of quinolone-resistant, topoisomerase-mutant Brucella after treatment with fluoroquinolones in a macrophage experimental infection model.
Rodríguez Tarazona E; García Rodríguez JÁ; Muñoz Bellido JL
Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):248-52. PubMed ID: 24913992
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
[TBL] [Abstract][Full Text] [Related]
3. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis.
Valdezate S; Navarro A; Medina-Pascual MJ; Carrasco G; Saéz-Nieto JA
J Antimicrob Chemother; 2010 Jan; 65(1):51-3. PubMed ID: 19861338
[TBL] [Abstract][Full Text] [Related]
4. In vitro selection of fluoroquinolone resistance in Brucella melitensis.
Ravanel N; Gestin B; Maurin M
Int J Antimicrob Agents; 2009 Jul; 34(1):76-81. PubMed ID: 19261448
[TBL] [Abstract][Full Text] [Related]
5. In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA.
Turkmani A; Psaroulaki A; Christidou A; Chochlakis D; Tabaa D; Tselentis Y
Int J Antimicrob Agents; 2008 Sep; 32(3):227-32. PubMed ID: 18583100
[TBL] [Abstract][Full Text] [Related]
6. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
Yan M; Sahin O; Lin J; Zhang Q
J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
[TBL] [Abstract][Full Text] [Related]
7. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
[TBL] [Abstract][Full Text] [Related]
9. Mutant prevention concentrations of fluoroquinolones against Campylobacter jejuni isolated from chicken.
Wang L; Yuanshu Z; Yuhan Z; Yaojie ; Yingxia L
Vet Microbiol; 2010 Aug; 144(3-4):409-14. PubMed ID: 20226601
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.
Noguchi N; Okihara T; Namiki Y; Kumaki Y; Yamanaka Y; Koyama M; Wakasugi K; Sasatsu M
Int J Antimicrob Agents; 2005 May; 25(5):374-9. PubMed ID: 15848290
[TBL] [Abstract][Full Text] [Related]
11. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
12. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
13. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
Bhagwat SS; Mundkur LA; Gupte SV; Patel MV; Khorakiwala HF
Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
[TBL] [Abstract][Full Text] [Related]
14. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
Preisler A; Heisig P
J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
[TBL] [Abstract][Full Text] [Related]
15. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
[TBL] [Abstract][Full Text] [Related]
16. Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.
Rafii F; Park M; Novak JS
Antimicrob Agents Chemother; 2005 Feb; 49(2):488-92. PubMed ID: 15673722
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.
Aldred KJ; Blower TR; Kerns RJ; Berger JM; Osheroff N
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E839-46. PubMed ID: 26792518
[TBL] [Abstract][Full Text] [Related]
19. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.
Shultz TR; White PA; Tapsall JW
Antimicrob Agents Chemother; 2005 May; 49(5):1753-60. PubMed ID: 15855492
[TBL] [Abstract][Full Text] [Related]
20. Droplet Digital PCR-Based Detection and Quantification of GyrA Thr-86-Ile Mutation Based Fluoroquinolone-Resistant Campylobacter jejuni.
Luo Y; Zhang W; Cheng Y; Lu Q; Guo Y; Wen G; Shao H; Cheng Z; Luo Q; Zhang T
Microbiol Spectr; 2022 Apr; 10(2):e0276921. PubMed ID: 35412390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
